Analysts’ Updated EPS Estimates for October 7th (ABEV, ACI, ADEA, AFYA, ANF, AZN, BE, BOWL, CAML, CATX)

Analysts’ updated eps estimates for Wednesday, October 7th:

Ambev (NYSE:ABEV) had its underperform rating reiterated by analysts at Bank of America Corporation. Bank of America Corporation currently has a $3.30 price target on the stock.

Albertsons Companies (NYSE:ACI) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $13.00 price target on the stock.

Adeia (NASDAQ:ADEA) had its buy rating reissued by analysts at BWS Financial. The firm currently has a $50.00 target price on the stock.

Afya (NASDAQ:AFYA) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $19.00 price target on the stock, down from their previous price target of $21.00.

Abercrombie & Fitch (NYSE:ANF) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $175.00 target price on the stock.

AstraZeneca (LON:AZN) had its buy rating reissued by analysts at Berenberg Bank. They currently have a £175 price target on the stock.

AstraZeneca (LON:AZN) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a £175 target price on the stock.

Bloom Energy (NYSE:BE) had its market perform rating reissued by analysts at Sanford C. Bernstein. The firm currently has a $282.00 target price on the stock.

Hollywood Bowl Group (LON:BOWL) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 450 target price on the stock.

Central Asia Metals (LON:CAML) had its hold rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 160 target price on the stock.

Perspective Therapeutics (NYSEAMERICAN:CATX) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $14.00 target price on the stock.

Coinbase Global (NASDAQ:COIN) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $240.00 price target on the stock.

Caribou Biosciences (NASDAQ:CRBU) had its hold rating reaffirmed by analysts at Brookline Capital Markets.

Gresham House Energy Storage (LON:GRID) had its buy rating reiterated by analysts at Jefferies Financial Group Inc..

Gore Street Energy Storage Fund (LON:GSF) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc..

Harrow (NASDAQ:HROW) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $63.00 price target on the stock.

Hostelworld Group (LON:HSW) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd. The firm currently has a GBX 220 target price on the stock.

HubSpot (NYSE:HUBS) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $200.00 price target on the stock.

Humana (NYSE:HUM) was upgraded by analysts at Cantor Fitzgerald from a neutral rating to an overweight rating. They currently have $460.00 price target on the stock, up from their previous price target of $300.00.

Hut 8 (NASDAQ:HUT) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $130.00 price target on the stock.

Johnson & Johnson (NYSE:JNJ) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $287.00 target price on the stock.

Manolete Partners (LON:MANO) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 67 price target on the stock.

Moelis & Company (NYSE:MC) was upgraded by analysts at UBS Group AG from a sell rating to a neutral rating. They currently have $59.00 price target on the stock.

Netcall (LON:NET) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 165 target price on the stock.

Nichols (LON:NICL) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 1,750 target price on the stock.

Owens Corning (NYSE:OC) was downgraded by analysts at Vertical Research from a hold rating to a sell rating. The firm currently has $106.00 price target on the stock.

Option Care Health (NASDAQ:OPCH) had its market perform rating reiterated by analysts at Barrington Research.

Option Care Health (NASDAQ:OPCH) had its market perform rating reiterated by analysts at Citizens Jmp.

PJT Partners (NYSE:PJT) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $159.00 target price on the stock, down from their previous target price of $195.00.

Rocket Pharmaceuticals (NASDAQ:RCKT) had its buy rating reissued by analysts at Chardan Capital. The firm currently has a $11.00 price target on the stock.

Rocket Pharmaceuticals (NASDAQ:RCKT) had its outperform rating reiterated by analysts at Wedbush.

Savannah Resources (LON:SAV) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 11 target price on the stock.

Simulations Plus (NASDAQ:SLP) had its neutral rating reiterated by analysts at BTIG Research.

ServiceTitan (NASDAQ:TTAN) had its buy rating reiterated by analysts at TD Cowen. The firm currently has a $100.00 target price on the stock.

Uber Technologies (NYSE:UBER) had its market outperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $100.00 target price on the stock.

Unusual Machines (NYSEAMERICAN:UMAC) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $40.00 target price on the stock.

UWM (NYSE:UWMC) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. They currently have $1.50 target price on the stock.

Wealthfront (NASDAQ:WLTH) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $13.00 price target on the stock.

Zscaler (NASDAQ:ZS) had its neutral rating reaffirmed by analysts at BTIG Research.

Zscaler (NASDAQ:ZS) had its buy rating reaffirmed by analysts at Truist Financial Corporation. The firm currently has a $250.00 price target on the stock, up from their previous price target of $200.00.

Zscaler (NASDAQ:ZS) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $236.00 target price on the stock.